Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Curcumin inhibits human non-small cell lung cancer xenografts by targeting STAT3 pathway.

Xu X, Zhu Y.

Am J Transl Res. 2017 Aug 15;9(8):3633-3641. eCollection 2017.

2.

CXCL12 overexpression promotes the angiogenesis potential of periodontal ligament stem cells.

Zhang L, Zhou Y, Sun X, Zhou J, Yang P.

Sci Rep. 2017 Aug 31;7(1):10286. doi: 10.1038/s41598-017-10971-1.

3.

VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug.

Kim M, Jang K, Miller P, Picon-Ruiz M, Yeasky TM, El-Ashry D, Slingerland JM.

Oncogene. 2017 Sep 7;36(36):5199-5211. doi: 10.1038/onc.2017.4. Epub 2017 May 15.

4.

The Relationship between Adiponectin and Breast Cancer.

Erbay B, Yılmaz TU, Eraldemir C, Üren N, Tiryaki Ç, Ergül E, Utkan Z.

J Breast Health. 2016 Apr 1;12(2):67-71. doi: 10.5152/tjbh.2016.2881. eCollection 2016 Apr.

5.

A Novel Physiological Glycosaminoglycan-Deficient Splice Variant of Neuropilin-1 Is Anti-Tumorigenic In Vitro and In Vivo.

Hendricks C, Dubail J, Brohée L, Delforge Y, Colige A, Deroanne C.

PLoS One. 2016 Oct 31;11(10):e0165153. doi: 10.1371/journal.pone.0165153. eCollection 2016.

6.

Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis.

Su JC, Mar AC, Wu SH, Tai WT, Chu PY, Wu CY, Tseng LM, Lee TC, Chen KF, Liu CY, Chiu HC, Shiau CW.

Sci Rep. 2016 Jul 1;6:28888. doi: 10.1038/srep28888.

7.

Inhibition of primary breast tumor growth and metastasis using a neuropilin-1 transmembrane domain interfering peptide.

Arpel A, Gamper C, Spenlé C, Fernandez A, Jacob L, Baumlin N, Laquerriere P, Orend G, Crémel G, Bagnard D.

Oncotarget. 2016 Aug 23;7(34):54723-54732. doi: 10.18632/oncotarget.10101.

8.

Onbaekwon Suppresses Colon Cancer Cell Invasion by Inhibiting Expression of the CXC Chemokine Receptor 4.

Kim B, Yoon J, Yoon SW, Park B.

Integr Cancer Ther. 2017 Jun;16(2):244-251. doi: 10.1177/1534735416645182. Epub 2016 May 9.

9.

Phenotypic and Functional Characterization of Mesenchymal Stem/Multipotent Stromal Cells from Decidua Basalis of Human Term Placenta.

Abomaray FM, Al Jumah MA, Alsaad KO, Jawdat D, Al Khaldi A, AlAskar AS, Al Harthy S, Al Subayyil AM, Khatlani T, Alawad AO, Alkushi A, Kalionis B, Abumaree MH.

Stem Cells Int. 2016;2016:5184601. doi: 10.1155/2016/5184601. Epub 2016 Feb 10.

10.

Co-option of Liver Vessels and Not Sprouting Angiogenesis Drives Acquired Sorafenib Resistance in Hepatocellular Carcinoma.

Kuczynski EA, Yin M, Bar-Zion A, Lee CR, Butz H, Man S, Daley F, Vermeulen PB, Yousef GM, Foster FS, Reynolds AR, Kerbel RS.

J Natl Cancer Inst. 2016 Apr 8;108(8). doi: 10.1093/jnci/djw030. Print 2016 Aug.

11.

The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells.

Labrecque MP, Takhar MK, Nason R, Santacruz S, Tam KJ, Massah S, Haegert A, Bell RH, Altamirano-Dimas M, Collins CC, Lee FJ, Prefontaine GG, Cox ME, Beischlag TV.

Oncotarget. 2016 Apr 26;7(17):24284-302. doi: 10.18632/oncotarget.8301.

12.

CXCR4 in breast cancer: oncogenic role and therapeutic targeting.

Xu C, Zhao H, Chen H, Yao Q.

Drug Des Devel Ther. 2015 Aug 28;9:4953-64. doi: 10.2147/DDDT.S84932. eCollection 2015. Review.

13.

Eupolyphaga sinensis Walker Ethanol Extract Suppresses Cell Growth and Invasion in Human Breast Cancer Cells.

Zhan Y, Zhang H, Liu R, Wang W, Qi J, Zhang Y.

Integr Cancer Ther. 2016 Mar;15(1):102-12. doi: 10.1177/1534735415598224. Epub 2015 Aug 4.

14.

Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers.

Oku Y, Nishiya N, Shito T, Yamamoto R, Yamamoto Y, Oyama C, Uehara Y.

FEBS Open Bio. 2015 Jun 22;5:542-9. doi: 10.1016/j.fob.2015.06.007. eCollection 2015.

15.

Bone Marrow-Derived Mesenchymal Stem Cells Repair Necrotic Pancreatic Tissue and Promote Angiogenesis by Secreting Cellular Growth Factors Involved in the SDF-1 α /CXCR4 Axis in Rats.

Qian D, Gong J, He Z, Hua J, Lin S, Xu C, Meng H, Song Z.

Stem Cells Int. 2015;2015:306836. doi: 10.1155/2015/306836. Epub 2015 Feb 25.

16.

p53-dependent expression of CXCR5 chemokine receptor in MCF-7 breast cancer cells.

Mitkin NA, Hook CD, Schwartz AM, Biswas S, Kochetkov DV, Muratova AM, Afanasyeva MA, Kravchenko JE, Bhattacharyya A, Kuprash DV.

Sci Rep. 2015 Mar 19;5:9330. doi: 10.1038/srep09330.

17.

A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR4.

Zhan Y, Zhang H, Li J, Zhang Y, Zhang J, He L.

J Cell Mol Med. 2015 Jul;19(7):1614-23. doi: 10.1111/jcmm.12536. Epub 2015 Mar 8.

18.

Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer.

Xu Q, Wang Z, Chen X, Duan W, Lei J, Zong L, Li X, Sheng L, Ma J, Han L, Li W, Zhang L, Guo K, Ma Z, Wu Z, Wu E, Ma Q.

Oncotarget. 2015 Mar 10;6(7):4717-32.

19.

The emerging role of class-3 semaphorins and their neuropilin receptors in oncology.

Nasarre P, Gemmill RM, Drabkin HA.

Onco Targets Ther. 2014 Sep 24;7:1663-87. doi: 10.2147/OTT.S37744. eCollection 2014. Review.

20.

Prostanoid induces premetastatic niche in regional lymph nodes.

Ogawa F, Amano H, Eshima K, Ito Y, Matsui Y, Hosono K, Kitasato H, Iyoda A, Iwabuchi K, Kumagai Y, Satoh Y, Narumiya S, Majima M.

J Clin Invest. 2014 Nov;124(11):4882-94. doi: 10.1172/JCI73530. Epub 2014 Oct 1.

Supplemental Content

Support Center